Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Advertising & Marketing

Sales

Legal & Regulatory

Acquisition & Integration

Goodwill impairment

Restructuring costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Teladoc

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company was founded on June 13, 2002, by George Byron Brooks and Gary Wald and is headquartered in Purchase, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Teladoc reports solid Q4 growth, eyes revenue optimization strategies

Teladoc's Q4 performance showed revenue growth and margin focus, with BetterHelp contributing significantly to profitability.
The company's strategic focus on virtual care expansion and revenue optimization positions Teladoc for continued success in the healthcare market.
While facing internal restructuring challenges, Teladoc's emphasis on growth drivers and operational efficiency presents opportunities for future growth and market leadership.

Teladoc Health excels in Q1, eyes growth and efficiency

Teladoc Health's Q1 performance was strong, with revenue exceeding expectations.
The company is focused on efficiency, innovation, and driving value in virtual care.
BetterHelp segment showed growth and stability, with improving margins expected.
Opportunities exist to capitalize on ad pricing stability and consumer behavior trends.

Teladoc surpasses revenue expectations, focuses on innovation and growth

Teladoc's Q2 performance exceeded expectations, with strong revenue growth and improved margins in both segments. The company's strategic focus on whole-person care, weight management, and AI enhancements positions it well for future growth. Challenges include managing drug costs and private company valuations, while opportunities lie in virtual care demand and strategic M&A.
Teladoc's financial strength, commitment to innovation, and focus on efficiency improvements are key strengths driving its performance. The company's ability to navigate challenges and capitalize on opportunities in the evolving healthcare landscape underscores its resilience and growth potential.

Teladoc Health surpasses Q3 expectations, eyes margin expansion in '24

Teladoc Health's Q3 performance exceeded expectations, driven by revenue growth and margin improvements.
The company is focused on enhancing cost efficiencies, profitability, and driving margin expansion.
Stable pricing environment and strong client demand present opportunities for future growth.
Operational review and strategic initiatives position Teladoc for continued success in the healthcare sector.

Teladoc reports robust 2023 earnings, eyes growth amid marketing challenges

Teladoc delivered strong financial performance in 2023 with notable growth in adjusted EBITDA and revenue. The company faces challenges in BetterHelp marketing yields and delayed consumer engagement efforts.
However, Teladoc's strategic strengths lie in its long-term outlook for revenue growth, margin expansion, and cost-saving initiatives. Opportunities exist in optimizing sales force structure and capital deployment for future growth.
Overall, Teladoc's focus on profitability, growth optimization, and strategic capital allocation positions it well for sustained success in the telehealth industry.

Teladoc Health reports solid Q1 performance amidst revenue challenges

Teladoc Health's Q1 2024 performance showcased revenue growth in Integrated Care but challenges in BetterHelp segment revenue and margin management.
The company's financial strength, product portfolio, and cost initiatives position it well for growth opportunities and strategic market positioning.
Addressing challenges in ad spend management and focusing on international market efficiency are key to unlocking growth potential and improving financial performance.
Overall, Teladoc's performance, strengths, challenges, and opportunities reflect a dynamic landscape with strategic focus on sustainable growth and operational efficiency.

Teladoc Health reports Q2 revenue dip, EBITDA growth; addresses challenges

Teladoc Health's Q2 2024 performance showed mixed results with revenue decline but EBITDA growth. The company is leveraging strengths in patient safety and technology while addressing challenges in customer acquisition costs. Opportunities lie in operational efficiency, insurance coverage access, and international expansion.

Teladoc Health reports Q3 revenue decline but strategic growth

Teladoc Health's Q3 2024 performance reflects mixed results with revenue decline but strategic growth in the Integrated Care segment.
The company's focus on customer-centric strategies, technology, and clinical excellence positions it well for future success and market leadership.
Challenges in revenue decline and expense management require Teladoc Health to balance short-term financial performance with long-term growth objectives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002, by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in Purchase, NY.

The telehealth industry is built to last.

Don't Let Competition Stop You From Investing in Teladoc

Lucid Group

UiPath

These are the best tech stocks to invest in now. They can make great investments in the coming weeks and quarters.

3 Disruptive Tech Stocks to Buy for Game-Changing Profits

Investors might not be giving this telehealth titan enough credit.

3 Things About Teladoc Health That Smart Investors Know

TDOC stock has a tremendous long-term opportunity ahead, benefitting immensely from pandemic-led digital transformation. The post The Opportunity in Teledoc Extends Far Beyond the Pandemic appeared first on InvestorPlace.

The Opportunity in Teledoc Extends Far Beyond the Pandemic

TDOC stock is trading at levels not seen since the pandemic began. Revenue is up, but so is short interest -- and something has to give.

Teladoc Health Can Move Higher if Short Sellers Get Out of the Way

Teladoc will leverage partnerships with big tech to drive growth. The market looks at the wrong metrics and Investor Relations is to blame.

Teladoc's Misunderstood Story And Partnerships With Big Tech Make It A Buy Here

Intuitive Surgical

Merck

These are the best healthcare stocks to invest in now. ISRG, MRK and TDOC can make great investments in the coming months.

3 Healthcare Stocks That Are Looking Even Healthier

Alphabet

Vertex Pharmaceuticals

Bear, shmear. These stocks are great picks to buy no matter what the Nasdaq does next.

Another Nasdaq Bear Market on the Way? 3 Great Stocks to Buy Anyway

Expectations are rising ahead of the telehealth giant's earnings release.

Why Teladoc Health Stock Is Surging Today

BARK

Root

These fast-paced stocks have the competitive advantages needed to make their shareholders richer.

3 Growth Stocks Down 79% (or More) That Can Double by 2025

Doximity

Shopify

Zoom Video

These Ridiculously Cheap Stocks Are Obvious Winners

Is Doximity or Teladoc the better investment right now?

2 Outstanding Healthcare Companies With Huge Potential

Prior to the coronavirus pandemic, Teladoc (NYSE:TDOC) was growing rapidly. The global health crisis accelerated that growth.

One of ARK Invest's Favorite Stocks Offers Big Rebound Potential

Guggenheim Partners initiates coverage on shares of the telehealth provider at Buy, citing optimism over the company's growth prospects.

Teladoc Has a 'Track Record of Delivering.' That's Why the Stock Is a Buy.

Teladoc Health Inc (NYSE:TDOC) stock is higher ahead of the opening bell, last seen up 1.2% to trade at $68.49 after Guggenheim initiated coverage.

Teladoc Stock Boosted By Fresh Analyst Coverage

Brookfield Renewable Partners

Upstart Holdings

The growth potential in these stocks is so strong that you could win big if you buy them now.

Buy the Dip: 3 Stocks to Buy in April and Hold for the Next 3 Years

Blame it on the Fed -- or at least fears about what the Fed might do.

Why Teladoc Health Stock Is Tumbling Today

PURCHASE, NY, April 06, 2022 (GLOBE NEWSWIRE) -- Teladoc Health , Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced that it will release first quarter 2022 results on Wednesday, April 27, 2022, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day.

Teladoc Health to Announce First Quarter 2022 Financial Results

By avoiding memes and sticking to a long-term strategy, you can minimize your portfolio's risk.

2 Reasons Why Now Could Be a Great Time to Become a Long-Term Investor

Farfetch

Although out of investor favor for now, these fundamentally strong stocks have all that it takes for a solid rebound.

Down Over 50%, 2 Unstoppable Growth Stocks to Buy Right Now

ARK Innovation ETF

Block

The Ark Innovation Fund (ARKK) stock price has rebounded in the past few weeks as investors price in a resurgence of technology stocks. The fund is trading at $70.50, which is about 35% above the lowest level this year.

ARKK ETF is staging a comeback. 3 constituents to buy

Teladoc Health's stock has plunged from the all-time high levels of nearly $294 a share, and it now trades at a reasonable valuation.

Teladoc Health: A Rare Growth Opportunity At A Reasonable Price

Pinterest

Bargains abound for patient growth-seeking investors who want to become millionaires.

3 Beaten-Down Growth Stocks That Can Turn $300,000 Into $1 Million by 2030

DocGo

Patient care via phone and video is far from finished.

2 TeleHealth Stocks to Buy, 1 to Watch in 2022

As age demographics shift, Teladoc will be the beneficiary of this social shift for years to come.

News for Teladoc Stock (TDOC)